ClariTrial | Search Clinical Trials

Explore/eye disease ophthalmology retina

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

155 results for “eye disease ophthalmology retina” · Recruiting

Page 1 of 11

Recruiting

SGLT2 Inhibitors in Geographic Atrophy

Phase 2Retinal DegenerationRetinal DiseasesEye Diseases

DapagliflozinMatching Placebo

Washington University School of Medicine70 participants1 site · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Reliability of Optical and Ultrasound Biometry in Silicon Filled Eyes

N/ARetinal Detachment

optical and ulrtasound biometry

Sohag University100 participants1 site · EgyptCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Spring Loaded Syringe for Active Silicon Oil Extraction

N/ARetinal Detachment

Vitrectomy machineSpring loaded syringe

Sohag University200 participants1 site · EgyptCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Phenotypic and Etiological Characterization of Susac Syndrome

N/ASusac Syndrome

Assistance Publique - Hôpitaux de Paris180 participants1 site · FranceCompletes Nov 2044

Compare CT.gov Full analysis →

Recruiting

Electrical Stimulation for the Treatment of Optic Neuropathies

N/AGlaucomaGlaucoma, Open-AngleOptic Nerve Diseases

Repetitive, Transorbital Alternating Current Stimulation (rtACS)

Stanford University40 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

Phase 2Geographic Atrophy Secondary to Age-related Macular Degeneration

APL-3007, pegcetacoplan (APL-2)APL-3007, pegcetacoplan (APL-2)Placebo, Syfovre

Apellis Pharmaceuticals, Inc.240 participants78 sites · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants

N/AAge Related Macular Degeneration

Blood samples

Hospices Civils de Lyon80 participants2 sites · FranceCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies

N/AMacular EdemaInherited Retinal DystrophyLaser Retinopathy

subthreshold treatment with micropulsed laser

Fondazione G.B. Bietti, IRCCS10 participants1 site · ItalyCompletes Jul 2025

Compare CT.gov Full analysis →

Recruiting

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Phase 1Phase 2Diabetic Macular Edema

Low dose BI 3812465Medium dose BI 3812465High dose BI 3812465

Boehringer Ingelheim49 participants30 sites · United States, Puerto RicoCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

Study of BEST1 Vitelliform Macular Dystrophy

N/ABest Vitelliform Macular DystrophyRetinitis Pigmentosa

Natural History Study

Columbia University52 participants3 sites · United States, France, GermanyCompletes May 2026

Compare CT.gov Full analysis →

Recruiting

Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma

N/AGlaucomaPrimary Open Angle GlaucomaPseudoexfoliation Glaucoma

Transcorneal electrical stimulation (TES) with the OkuStim 2 System

Okuvision GmbH50 participants1 site · GermanyCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy

N/AHidroxicloroquine Intake

Retinopathy groupControl group

Centro Hospitalar de Lisboa Central100 participants1 site · PortugalCompletes Apr 2025

Compare CT.gov Full analysis →

Recruiting

"My Eyes, My Light": Amar Chokh, Amar Alo

N/AGlaucomaDiabetic Retinopathy (DR)Hypertensive Retinopathy

Multimodal Screening for Eye Diseasecataract surgery

Data Yakka, Inc.20,000 participants1 site · BangladeshCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

MMP-9 Inhibition for Recalcitrant Wet AMD

Phase 2Exudative Macular DegenerationWet Age-related Macular Degeneration

Doxycycline HyclatePlacebo

University of Iowa50 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

Phase 2Macular Edema

BI 1815368Placebo

Boehringer Ingelheim300 participants90 sites · United States, China, CzechiaCompletes Sep 2027

Compare CT.gov Full analysis →

1–15 of 155

Explore/eye disease ophthalmology retina

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

155 results for “eye disease ophthalmology retina” · Recruiting

Page 1 of 11

Recruiting

SGLT2 Inhibitors in Geographic Atrophy

Phase 2Retinal DegenerationRetinal DiseasesEye Diseases

DapagliflozinMatching Placebo

Washington University School of Medicine70 participants1 site · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Reliability of Optical and Ultrasound Biometry in Silicon Filled Eyes

N/ARetinal Detachment

optical and ulrtasound biometry

Sohag University100 participants1 site · EgyptCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Spring Loaded Syringe for Active Silicon Oil Extraction

N/ARetinal Detachment

Vitrectomy machineSpring loaded syringe

Sohag University200 participants1 site · EgyptCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Phenotypic and Etiological Characterization of Susac Syndrome

N/ASusac Syndrome

Assistance Publique - Hôpitaux de Paris180 participants1 site · FranceCompletes Nov 2044

Compare CT.gov Full analysis →

Recruiting

Electrical Stimulation for the Treatment of Optic Neuropathies

N/AGlaucomaGlaucoma, Open-AngleOptic Nerve Diseases

Repetitive, Transorbital Alternating Current Stimulation (rtACS)

Stanford University40 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Phase 2Geographic Atrophy Secondary to Age-related Macular Degeneration

APL-3007, pegcetacoplan (APL-2)APL-3007, pegcetacoplan (APL-2)Placebo, Syfovre

Apellis Pharmaceuticals, Inc.240 participants78 sites · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants

N/AAge Related Macular Degeneration

Blood samples

Hospices Civils de Lyon80 participants2 sites · FranceCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies

N/AMacular EdemaInherited Retinal DystrophyLaser Retinopathy

subthreshold treatment with micropulsed laser

Fondazione G.B. Bietti, IRCCS10 participants1 site · ItalyCompletes Jul 2025

Compare CT.gov Full analysis →

Recruiting

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Phase 1Phase 2Diabetic Macular Edema

Low dose BI 3812465Medium dose BI 3812465High dose BI 3812465

Boehringer Ingelheim49 participants30 sites · United States, Puerto RicoCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

Study of BEST1 Vitelliform Macular Dystrophy

N/ABest Vitelliform Macular DystrophyRetinitis Pigmentosa

Natural History Study

Columbia University52 participants3 sites · United States, France, GermanyCompletes May 2026

Compare CT.gov Full analysis →

Recruiting

Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma

N/AGlaucomaPrimary Open Angle GlaucomaPseudoexfoliation Glaucoma

Transcorneal electrical stimulation (TES) with the OkuStim 2 System

Okuvision GmbH50 participants1 site · GermanyCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy

N/AHidroxicloroquine Intake

Retinopathy groupControl group

Centro Hospitalar de Lisboa Central100 participants1 site · PortugalCompletes Apr 2025

Compare CT.gov Full analysis →

Recruiting

"My Eyes, My Light": Amar Chokh, Amar Alo

N/AGlaucomaDiabetic Retinopathy (DR)Hypertensive Retinopathy

Multimodal Screening for Eye Diseasecataract surgery

Data Yakka, Inc.20,000 participants1 site · BangladeshCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

MMP-9 Inhibition for Recalcitrant Wet AMD

Phase 2Exudative Macular DegenerationWet Age-related Macular Degeneration

Doxycycline HyclatePlacebo

University of Iowa50 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

Phase 2Macular Edema

BI 1815368Placebo

Boehringer Ingelheim300 participants90 sites · United States, China, CzechiaCompletes Sep 2027

Compare CT.gov Full analysis →

1–15 of 155